TDP-43 mitochondrial localization inhibitor for the treatment of neurogenerative disease
US11124553B2 · kind B2 · utility
0Cited by
3References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 7, 2017 |
| Grant date | Sep 21, 2021 |
| Priority date | — |
| Expiry date | Apr 7, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a neurodegenerative disease in a subject includes administering to the subject a therapeutically effective amount of a TDP-43 mitochondrial localization inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.